Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

June 5, 2025

Study Completion Date

December 5, 2025

Conditions
Breast Cancer Recurrent
Interventions
DRUG

Utidelone Capsule Plus Capecitabine

"Utidelone Capsule: 60mg/m2/d, once daily, oral on an empty stomach, continuously administered for 1-5 days; Capecitabine tablets: 1000mg/m2, twice a day (daily dose 2000mg/m2), once in the morning and once in the evening, taken orally within 30 minutes after meals, and continuously administered for 14 days from day 1 to day 14.~Every 21 days is a cycle ."

Trial Locations (1)

Unknown

RECRUITING

Henan Cancer hospital, Zhengzhou

All Listed Sponsors
collaborator

Beijing Biostar Pharmaceuticals Co., Ltd.

INDUSTRY

lead

Min Yan, MD

OTHER_GOV